During 1998, progress has been made in the identification of specific genes that are responsible for, or predispose to, endocrine disorders. Several genetic abnormalities of the thyroid have been described, such as two new mutations in exon 10 of the thyrotropin-receptor gene, resulting in a clinical picture of thyroid hypoplasia and congenital hypothyroidism as well as germ-line neo-mutations in the extracellular portion of the thyrotropin receptor, leading to an opposite clinical picture of severe congenital hyperthyroidism. In addition to previously disovered mutations, new mutations in the PIT-I and the PROP-I gene, responsible for combined pituitary hormone deficiency, have been reported. In patients with septo-optic dysplasia a mutation in the homeobox gene HESXI/Hesxl was found, indicating that the gene plays an important role in the development of Will the forebrain, midline, and pituitary. Growth hormone insensitivity syndrome (GHIS) is now associated with'a broad spectrum of mutations of the GH receptor gene. Woods and colleagues showed that GHIS is, a highly variable condition--from severely affected patients with classical GH insensitivity to a larger group of with idiopathic short stature. Other genetic and/or environmental factors must, therefore, contribute to the phenotype. Intriguing results were found when families with LeriWeill dyschondrosteosis (LWD), a dominant inherited skeletal dysplasia characterised by disproportionate short stature with mesomelic limb shortening, were studied. Various mutations of the short stature homeoboxcontaining gene (SHOX) were found in patients with LWD. These S H O X mutations, however, have also been found in idiopathic growth retardation and Turner (XO) short stature, conditions without bone dysplasia. One explanation is that loss of other genes from the nonpseudoautosomal region of the X chromosome in Turner 's syndrome may mask the full phenotype of S H O X haploinsufficiency. The variable expression in families segretating for a S H O X deletion or mutation suggests that there may be a modifying gene, or genes, on an autosome or on the X chromosome itself, and background genetic effects and environmental factors may also play a role. The mentioned genetic disorders are just examples. Reports about various mutations have appeared in 1998, indicating that in the coming, years many endocrine disorders will be found to be genetically determined. Research in the field of obesity and leptin has progressed. In a large population of massively obese people, however, no mutations of the leptin receptor were found. Feeding behaviour and caloric balance are also modified by neuronal effectors such as neuropeptide Y,